ASTRO Journals

Sue Yom, our Editor in Chief, leads a discussion of Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical Trials , a critical review from AAPM and NRG Oncology. Guests are first author Dr. Heng Li, Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University and Chief Proton Phy...

Editor-in-Chief, Robert Amdur, MD, discusses using SBRT dose schedules to re-irradiate large volume recurrences of locally advanced Non-Small Cell Lung Cancer that has progressed following high-dose radiotherapy with conventional fractionation. The discussion is based on a paper published in the May 2024 issue of PRO titled " Thoracic Reirradiation with Stereotactic Body Radiation Therapy (SBRT) f...

Editor-in-Chief Sue Yom hosts Dr. Ralph Ermoian, Associate Professor from the University of Washington and Dr. Kilian Salerno, Associate Research Physician from the National Cancer Institute, our two successive Pediatric/Sarcoma Section Editors who supervised the PEdiatric Normal Tissue Effects in the Clinic (PENTEC) peer review process for our journal. We also welcome two representatives from the...

Editor-in-Chief, Robert Amdur, MD, discusses two papers published in PRO related to the question of using a vaginal dilator during radio-chemotherapy for carcinoma of the anus: " Daily Vaginal Dilator Use During Radiation for Women With Squamous Cell Carcinoma of the Anus: Vaginal Wall Dosimetry and Patient-Reported Sexual Function " (2024, Volume 14, Issue 2, PMID 37898354) and " ECOG-ACRIN Guide...

Editor-in-Chief Sue Yom hosts a British-American conversation about brachytherapy. Guests include Dr. Mahbuba Choudhury, Clinical Oncology Registrar and Stereotactic Radiotherapy Fellow at Imperial College London NHS Trust, and Dr. Imtiaz Ahmed, Consultant Clinical Oncologist and Clinical Lead at Southend University Hospital in the UK, first and supervising authors on this month’s paper...

Editor-in-Chief, Robert Amdur, MD, discusses a paper from the March 2024 issue of PRO: " Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy " (Volume 14 Issue 2, PMID 37984711). This paper suggests V5, V20, and Mean Lung Dose values to minimize grade ≥2 pneumonitis when treating lung cancer with the moderate hypofractionation programs of 60 or 72 Gy a...

Sue Yom, our Editor-in-Chief, co-hosts with Dr. Salma Jabbour, Deputy Editor at the Red Journal and Professor, Vice Chair of Clinical Research and Faculty Development, and Clinical Chief of the Department of Radiation Oncology at Rutgers University. Guests include Drs. Amar Kishan, Professor, Vice Chair of Clinical and Translational Research, and Chief of the Genitourinary Oncology Service, and Mi...

Editor-in-Chief, Robert Amdur, MD, discusses using molecular markers to make decisions about adjuvant radiotherapy for Endometrial Cancer. The main references for the podcast are the PROshot article in the January 2024 issue of PRO (2024, Issue 1, January/February) and a Topic Discussion paper currently published online ahead of print with title " Path to Precision: Refining Radiation Therapy Guid...

Editor-in-Chief Sue Yom hosts Dr. Lachlan McDowell, a consultant Radiation Oncologist at the Princess Alexandra Hospital and the first author of a new paper this month, "A longitudinal study evaluating sexual health outcomes and prioritization in patients undergoing chemoradiation for human papillomavirus-associated oropharyngeal cancer," Dr. Jie Deng, Professor of Nursing, Senior Fellow at the Le...

Editor-in-Chief Sue Yom co-hosts with Dr. Thomas Zilli, Associate Editor at the Red Journal and Professor and Director of the Department of Radiation Oncology at the Oncology Institute of Southern Switzerland. Dr. Zilli was co author on Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy , published in the Apri...

Editor-in-Chief, Robert Amdur, MD, discusses the issues related to using a rectal spacer with prostate radiotherapy that is both radiopaque and viscous. The foundation of the discussion is a paper published in the 2024 January/February issue of PRO: “ Application of a Radiopaque Viscous Hydrogel Spacer for Prostate Cancer Radiation Therapy: A Prospective Phase 2 Study ” with PMID 37791...

Editor-in-Chief Sue Yom co-hosts with Dr. Jose Bazan, Red Journal Associate Editor and Associate Professor and Director of Breast Radiation Oncology and Radiation Oncology Quality and Safety at City of Hope. Dr. Bazan first authored an editorial this month, Surgical De-Escalation in Breast Cancer: Qualitative Research Introduces Hope for Patients and Illuminates a Blind Spot within Blinded Studies...

Editor-in-Chief, Robert Amdur, MD, reviews the evidence for treating Low-Intermediate Risk prostate cancer with Ultra Hypofractionated SBRT. This discussion was stimulated by a paper published in the November/December 2023 issue of PRO titled " Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks " with...

Practical Radiation Oncology associate section editor, Sandra Meyers, PhD of University of California, San Diego, hosts a conversation on online adaptive radiotherapy, or the use of imaging to adapt radiation treatments to the anatomy observed each day. Lauren Henke, MD of University Hospitals Cleveland Medical Center and Bin Cai, PhD of UT Southwestern Medical Center discuss their clinical experi...

Sue Yom, Editor-in-Chief, co-hosts with Dr. Michelle Kim, Professor and Co-Chair of the Cancer Center's Neuro-Oncology Clinical Research Team at the University of Michigan, and our journal’s section lead for the CNS section. Our guests are Dr. Joshua Palmer, Associate Professor at Ohio State University and supervising author on the article, Dose/volume tolerance of the brain and predictors of radi...

Editor-in-Chief Sue Yom hosts Dr. Karin Lindberg, a Clinical Oncologist at the Karolinska Institute in Sweden and the supervising author of a new paper this month, " Expanded HILUS trial - a pooled analysis of risk factors for toxicity from SBRT of central and ultra-central lung tumors ," and Dr. David Palma, a Radiation Oncologist at the London Health Sciences Centre who co-authored the accompany...

Editor-in-Chief Sue Yom co-hosts with Dr. Jean Wright, Breast Section Editor and Associate Professor of Radiation Oncology and Director of the radiation oncology Breast Cancer Program at Johns Hopkins University. Joining is Dr. Juliane Hörner-Rieber, Managing Senior Physician and Associate Professor at the Department of Radiation Oncology of Heidelberg University Hospital, who was supervising auth...

Editor-in-Chief, Robert Amdur, MD, explains how radiation oncologists are using ChatGPT and other Large Language Model programs in clinical practice. The discussion is based on a paper published in the November/December 2023 issue of PRO titled " Unlocking the Power of ChatGPT, Artificial Intelligence, and Large Language Models: Practical Suggestions for Radiation Oncologists " (2023, Issue 6, Nov...

Dr. Sue Yom hosts Dr. Charles "Chuck" Mayo, Professor and Director of Radiation Oncology Informatics and Analytics at the University of Michigan and first author of an article in this month's issue, Operational Ontology for Oncology (O3) – A Professional Society-Based, Multi-Stakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of "Real-World" Data from Patients T...

Editor-in-Chief Dr. Sue Yom is joined this month by co-host Dr. Danielle Margalit, the Red Journal's Head and Neck Section Editor and Associate Professor of Radiation Oncology at Harvard Medical School. Guests are Dr. Adam Garden, Professor of Radiation Oncology at UT MD Anderson Cancer Center, who is the first author of an article in this month's issue, " Final Report of NRG Oncology RTOG 0022: A...

Practical Radiation Oncology associate editor Louis Potters, MD, of Northwell Health hosts a conversation on Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline . Two of the authors, Puneeth Iyengar MD, PhD of Memorial Sloan Kettering Cancer Center and Matthias Guckenberger MD of the University Hospital Zurich, along with patient advocate Jill Feldma...

Editor-in-Chief Dr. Sue Yom hosts a discussion this month on audiovisual technology in the service of patients, along with Pediatrics/Sarcoma Section Editor Dr. Ralph Ermoian, Associate Professor in the Department of Radiation Oncology at the University of Washington School of Medicine. Joining the discussion are Dr. Susan Hiniker, Assistant Professor of Radiation Oncology at Stanford University,...

Editor-in-Chief Dr. Sue Yom hosts a discussion this month on the role of radiotherapy in the optimal treatment of recurrent and refractory lymphoma. Guests include Dr. Belinda Campbell, the journal’s Section Editor of lymphoma and hematologic malignancies, Honorary Clinical Associate Professor at The University of Melbourne, and Deputy Director of Radiotherapy at Peter MacCallum Cancer Centre. We...

Editor-in-Chief Dr. Sue Yom and Physics Section and Executive Editor Dr. David Carlson, Professor, Vice Chair, and Director of Medical Physics at Yale University, host a discussion of current research frontiers in particle therapy. Our guests (calling in from PTCOG!) are Dr. Tracy Underwood, Senior Physicist at Leo Cancer Care and one of the supervising authors of Proposing a Clinical Model for RB...

Editor-in-Chief, Robert Amdur, MD, discusses radiotherapy dose prescription to positive pelvic or paraaortic nodes when treating a cervix cancer patient with primary chemo-radiotherapy. The discussion is based on a paper published in the May 2023 issue of PRO titled " Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Canc...